Skip to Content
Global News Select

Ecolab Flips to 2Q Profit as Sales Beat Expectations

By Allison Prang


Hygiene and infection prevention solutions company Ecolab Inc. reported a double-digit percentage rise in net sales and swung to a second-quarter profit.

The company's second-quarter net sales rose 18%, to $3.16 billion, from $2.69 billion a year ago. According to FactSet, analysts were expecting $3.11 billion.

Net income attributable to the company was $310.8 million, or $1.08 a share. For the year-ago period, the company's loss was $2.04 billion, or $6.98 a share. Adjusted earnings from continuing operations were $1.22 a share. Analysts were expecting $1.21 a share.

"We expect the U.S. recovery to continue, Europe to reopen as forecasted, the rest of the world to follow soon after, and a continued higher cost environment," Ecolab said. "We have implemented strong pricing actions in 2021 that remain ahead of input costs, and pricing will provide further coverage as it builds through the second half."

The company said it is still expecting earnings per share for the year to be higher than 2019 earnings per share from continuing operations not including the per-share Texas freeze effect.


Write to Allison Prang at


(END) Dow Jones Newswires

July 27, 2021 09:05 ET (13:05 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.